XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
 Additional Paid in Capital
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2019   51,846,011      
Beginning balance at Dec. 31, 2019 $ 14,453,550 $ 52,223 $ 144,843,687 $ (129,045,801) $ (1,396,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,825,236)     (2,825,236)  
Stock-based compensation 208,897   208,897    
Stock issued for vested restricted stock awards (in shares)   260,719      
Stock issued for vested restricted stock awards 0 $ 261 (261)    
Shares withheld for taxes on vest restricted stock (21,184)   (21,184)    
Convertible Note Conversion (in shares)   1,200,000      
Convertible Note Conversion 468,667 $ 1,200 467,467    
Sale of common stock, net (in shares)   7,046,429      
Sale of common stock, net 1,206,788 $ 7,046 1,199,742    
Ending balance (in shares) at Mar. 31, 2020   60,353,159      
Ending balance at Mar. 31, 2020 13,491,482 $ 60,730 146,698,348 (131,871,037) (1,396,559)
Beginning balance (in shares) at Dec. 31, 2019   51,846,011      
Beginning balance at Dec. 31, 2019 14,453,550 $ 52,223 144,843,687 (129,045,801) (1,396,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (4,184,524)        
Ending balance (in shares) at Jun. 30, 2020   75,775,666      
Ending balance at Jun. 30, 2020 18,074,532 $ 76,153 152,625,263 (133,230,325) (1,396,559)
Beginning balance (in shares) at Mar. 31, 2020   60,353,159      
Beginning balance at Mar. 31, 2020 13,491,482 $ 60,730 146,698,348 (131,871,037) (1,396,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (1,359,288)     (1,359,288)  
Stock-based compensation 193,288   193,288    
Convertible Note Conversion (in shares)   1,800,000      
Convertible Note Conversion 455,143 $ 1,800 453,343    
Sale of common stock, net (in shares)   13,622,507      
Sale of common stock, net 5,293,907 $ 13,623 5,280,284    
Ending balance (in shares) at Jun. 30, 2020   75,775,666      
Ending balance at Jun. 30, 2020 18,074,532 $ 76,153 152,625,263 (133,230,325) $ (1,396,559)
Beginning balance (in shares) at Dec. 31, 2020   98,035,829      
Beginning balance at Dec. 31, 2020 25,289,114 $ 98,036 161,541,448 (136,350,370)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,147,268)     (2,147,268)  
Stock-based compensation 394,870   394,870    
Stock issued for vested restricted stock awards (in shares)   1,467,465      
Stock issued for vested restricted stock awards 0 $ 1,467 (1,467)    
Shares withheld for taxes on vest restricted stock (161,244)   (161,244)    
Proceeds from exercise of options 1,569   1,569    
Sale of common stock, net (in shares)   19,015,151      
Sale of common stock, net 13,137,500 $ 19,016 13,118,484    
Ending balance (in shares) at Mar. 31, 2021   118,518,445      
Ending balance at Mar. 31, 2021 36,514,541 $ 118,519 174,893,660 (138,497,638)  
Beginning balance (in shares) at Dec. 31, 2020   98,035,829      
Beginning balance at Dec. 31, 2020 25,289,114 $ 98,036 161,541,448 (136,350,370)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (4,529,395)        
Ending balance (in shares) at Jun. 30, 2021   118,518,445      
Ending balance at Jun. 30, 2021 34,690,016 $ 118,519 175,451,262 (140,879,765)  
Beginning balance (in shares) at Mar. 31, 2021   118,518,445      
Beginning balance at Mar. 31, 2021 36,514,541 $ 118,519 174,893,660 (138,497,638)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,382,127)     (2,382,127)  
Stock-based compensation 557,602   557,602    
Ending balance (in shares) at Jun. 30, 2021   118,518,445      
Ending balance at Jun. 30, 2021 $ 34,690,016 $ 118,519 $ 175,451,262 $ (140,879,765)